おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Omniome
company
About
Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.
- 101 - 250
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $60M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2013
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy. Backed by leading life sciences venture investors and a proven management team, Omniome’s vision is to be the most trusted DNA sequencing platform and leader in clinical sequencing.Founded in 2013, the company is headquartered in San Diego, California, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$120M
Omniome has raised a total of
$120M
in funding over 2 rounds. Their latest funding was raised on
Jan 9, 2020 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 9, 2020 | Series C | $60M | 1 | — | — | Detail |
| Jul 31, 2018 | Series B | $60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Omniome is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
